Answers are grounded in this paper and cite their sources.
antitumor activity was systematically evaluated, and the results revealed that Ir-CA-1-3 and Ir-GFB-1-3 exhibited better anti-tumor activity than cisplatin. Among these compounds, Ir-CA-1 and Ir-GFB-1, which have the strongest anti-proliferative activity, were selected as representatives to evaluate their anti-tumor activity. Mechanistic studies revealed that Ir-CA-1 and Ir-GFB-1 could activate PPARα while inducing mitochondrial dysfunction, accompanied by a decrease in mitochondrial membrane potential (MMP) and excessive production of reactive oxygen species (ROS). Mitochondrial dysfunction triggered the intrinsic apoptotic pathway, as evidenced by the decreased Bcl-2 expression, increased Bax expression, and activation of caspase-3 induced by Ir-CA-1 and Ir-GFB-1. Moreover, Ir-CA-1 and Ir-GFB-1 exerted multimodal antitumor effects by triggering gasdermin E (GSDME)-mediated pyroptosis, which in turn induced immunogenic cell death (ICD), as evidenced by the release of lactate dehydrogenase (LDH) and ATP, as well as high mobility group box 1 protein (HMGB1) secretion and calreticulin (CRT) externalization. In addition, Ir-CA-1 and Ir-GFB-1 effectively suppressed the proliferation, colony formation, and migration of tumor cells in concentration- and time-dependent manners.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: